1Carmine S, Ernesto L, Schiffrin. Inflammation in hypertension [ J ]. Nephrology and Hypertension ,2006,15 : 152
2Dale B, Kelly A, Darren,et al. The cardiac fibroblast: Therapeutic target in myocardial remodeling and failure[ J]. Annu Rev Pharmacol Toxicol, 2005,45 : 657
3Marina RB,Ruey HK, Sylvia A,et al. Myocardial tumor necrosis factor -a secretion in hypertensive and heart failure -prone rats[J]. Physiol Heart Circ, 1999,277(2) :543
4Sherif F, Nagueh S J, Stetson N, et al. Decreased expression of tumor necrosis factor - a and regression of hypertrophy after nonsurgical septal reduction therapy for patients with hypertrophic obstructive cardiomyop- athy[ J]. Circulation ,2001,103 : 1844
5Sun Mei, Chen M, Dawood F, et al. Tumor necrosis factor - [alpha] mediates cardiac remodeling and ventrieular dysfunction after pressure overload state [ J ]. American Heart Association ,2007,115 ( 11 ) : 1398
7Christof S,lngcborg F, Douglas B. Inhibition of tumor necrosis factor- a improves postischemic recovery of hypertrophied hearts [ J ]. Circulation ,2001,104 : 1
8Bogdamki P, Kujawska LM, Lacki J, et al. Evaluation of selected interleukins,tumor necrosis factor,insulin and leptin in obese patient with hypertension [ J ]. Pol Merkufins Lek,2003,15 (88) :347
9Seiko M, Takafumi O, Sanae W. Effects of angiotensin Ⅱ receptor block- ade with valsartanon pro - Inflammatory cytokines in patients with essential gypertension[ J ]. Cardiovasc Pharmacol,2005,46 (6) :735
4[4]Feldman AM,Combes A,Wagner D,et al.The role of tumor necrosis factor in the pathophsiology of heart failure[J].JACC,2000,35:537-544.
5[8]Aukrust P,Yndestad A,Damas JK,et al.Therapeutic potential of anticytokine therapy in congestive heart failure[J].Am J Cardiovasc Drugs,2004,4:169-177.
6[11]Markus Flesch MD,Anje Hper MD,Louis D.Activation and functional significance of the renin-angiotensin system in mice with cardiac restricted overexpression of tumor necrosis factor[J].Circulation,2003,108:598-604.
7[12]Chen QM,Tu VC.Apoptosis and heart failure:mechanisms and therapeutic implications[J].Am J Cardiovasc Drugs,2002,2:43-57.
8TORRE-AMIONE G, KAPADIA S, LEE J, et al. Tumor necrosis factor receptors in the failing human heart [ J ]. Circulation,1996,93(4) :704.
9KIELY DG, CARGILL RI, STRUTHESS AD, et al. Cardiopulmonary effects of endothelin-1 in man[J ]. Cardiovasc Res, 1997,33(2) :378-382.
10Pfeffer JM,Pfeffer MA,Fisbein MC,et al.Myocardial infarct and ventricular function in rats.Circ Res,1979 ,44:503-512.
4Xu T,Ju Z, Tong W, et al. Relationship of C - reactive protein with hypertension and interactions between increased C - reac- tive protein and other risk factors on hypertension in Mongolian people,China[J]. Circ J,2008,72(8) : 1324 - 1328.
